FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for treating lymphedema. That is ensured by introducing a combination of full-length CCBE1 and VEGF-C, where CCBE1 and VEGF-C are in form of a polypeptide or polynucleotide. What is also presented is a pharmaceutical composition and a method of treating lymphedema.
EFFECT: group of inventions provides treating lymphedema by amplifying a full-length CCBE1 lymphangiogenic VEGF-C response.
5 cl, 11 dwg
